abstract |
The present invention provides it is a series of by lead to formula (I) represented by compounds and its pharmaceutically acceptable salt, solvate, polymorph or prodrug, comprising the pharmaceutical composition of these compounds, and with this compounds for treating as caused by the MCL-1 albumen for over-expressing or lacking of proper care or aggravate disease method. |